These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28682224)

  • 41. Linking the gut microbiota to human health.
    Robles Alonso V; Guarner F
    Br J Nutr; 2013 Jan; 109 Suppl 2():S21-6. PubMed ID: 23360877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotic administration and the development of obesity in children.
    Principi N; Esposito S
    Int J Antimicrob Agents; 2016 Mar; 47(3):171-7. PubMed ID: 26895606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gut microbiota and allogeneic transplantation.
    Wang W; Xu S; Ren Z; Jiang J; Zheng S
    J Transl Med; 2015 Aug; 13():275. PubMed ID: 26298517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Intestinal microbiota].
    Debré P; Le Gall JY;
    Bull Acad Natl Med; 2014 Dec; 198(9):1667-84. PubMed ID: 27356369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impacts of gut bacteria on human health and diseases.
    Zhang YJ; Li S; Gan RY; Zhou T; Xu DP; Li HB
    Int J Mol Sci; 2015 Apr; 16(4):7493-519. PubMed ID: 25849657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microbiota-based treatments in alcoholic liver disease.
    Sung H; Kim SW; Hong M; Suk KT
    World J Gastroenterol; 2016 Aug; 22(29):6673-82. PubMed ID: 27547010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Paradigm of dysbiosis in the modern gastroenterology. The role of microbiota in the treatment and prevention of diseases in the XXI century].
    Tkachenko EI
    Eksp Klin Gastroenterol; 2014; (5):4-8. PubMed ID: 25518493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations.
    Chu ND; Smith MB; Perrotta AR; Kassam Z; Alm EJ
    PLoS One; 2017; 12(1):e0170922. PubMed ID: 28125667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
    Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
    Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
    Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
    Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota and the development of pediatric diseases.
    Lu CY; Ni YH
    J Gastroenterol; 2015 Jul; 50(7):720-6. PubMed ID: 25917564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Probiotics, gut microbiota and health.
    Butel MJ
    Med Mal Infect; 2014 Jan; 44(1):1-8. PubMed ID: 24290962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microbial therapeutic interventions.
    Grady NG; Petrof EO; Claud EC
    Semin Fetal Neonatal Med; 2016 Dec; 21(6):418-423. PubMed ID: 27133778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of the microbiota on the host immune system.
    Karczewski J; Poniedziałek B; Adamski Z; Rzymski P
    Autoimmunity; 2014 Dec; 47(8):494-504. PubMed ID: 25019177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics.
    Serban DE
    Cancer Lett; 2014 Apr; 345(2):258-70. PubMed ID: 23981580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
    Escobedo G; López-Ortiz E; Torres-Castro I
    Rev Invest Clin; 2014; 66(5):450-9. PubMed ID: 25695388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
    Peterson CT; Sharma V; Elmén L; Peterson SN
    Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.